SearcharxivSearch

arXiv subjects

Seong Woo Han

Publications and source records attributed to Seong Woo Han.

5 recordsLinked to original sources

Hierarchical Bayesian Crowdsourcing with Item Difficulty

In applied statistics and machine learning, the gold standards used for training are often biased and almost always noisy. Dawid and Skene's justifiably popular crowdsourcing model adjusts for rater sensitivity and specificity, but fails to capture distributional properties of rating data gathered for training, which in turn biases training. In this study, we introduce a general purpose measurement-error model with which we can infer consensus categories by adding item-level effects for difficulty, discriminativeness, and guessability. We further show how to constrain the bimodal posterior of these models to avoid adversarial raters. We validate our model's goodness of fit with posterior predictive checks, the Bayesian analogue of $χ^2$ tests, and assess its predictive accuracy using leave-one-out cross-validation. We illustrate our new model with two well-studied data sets, binary rating data for caries in dental X-rays and implication in natural language.

cs.LG

iLENS: Interpretable LLM-Guided Mixture-of-Experts for Neuroimaging Survival Analysis

Alzheimer's Disease (AD) is a complex neurodegenerative disorder that continues to impact millions of people worldwide. Predicting AD conversion during the prodromal stage remains critical for disease understanding and patient care. As such, survival models are widely used for AD risk prediction, yet they are typically static predictors with limited interpretability and no capacity for natural language reasoning. In this work, we propose iLENS, an interpretable large language model (LLM) guided framework based on mixture-of-experts (MoE) for survival prediction in AD conversion. Our approach uses LLM to synthesize structured neuroimaging measurements and unstructured information to guide expert routing. Our framework demonstrates competitive predictive performance and capability in patient subtyping. Furthermore, our framework provides transparent, biologically grounded rationales for its routing decisions, bridging the gap between high-performance survival analysis and interpretable clinical decision support.

cs.LG

Large-Scale Bayesian Causal Discovery with Interventional Data

Inferring the causal relationships among a set of variables in the form of a directed acyclic graph (DAG) is an important but notoriously challenging problem. Recently, advancements in high-throughput genomic perturbation screens have inspired development of methods that leverage interventional data to improve model identification. However, existing methods still suffer poor performance on large-scale tasks and fail to quantify uncertainty. Here, we propose Interventional Bayesian Causal Discovery (IBCD), an empirical Bayesian framework for causal discovery with interventional data. Our approach models the likelihood of the matrix of total causal effects, which can be approximated by a matrix normal distribution, rather than the full data matrix. We place a spike-and-slab horseshoe prior on the edges and separately learn data-driven weights for scale-free and Erdős-Rényi structures from observational data, treating each edge as a latent variable to enable uncertainty-aware inference. Through extensive simulation, we show that IBCD achieves superior structure recovery compared to existing baselines. We apply IBCD to CRISPR perturbation (Perturb-seq) data on 521 genes, demonstrating that edge posterior inclusion probabilities enable identification of robust graph structures.

cs.LG

Bayesian Sensitivity Analyses for Policy Evaluation with Difference-in-Differences under Violations of Parallel Trends

Violations of the parallel trends assumption pose significant challenges for causal inference in difference-in-differences (DiD) studies, especially in policy evaluations where pre-treatment dynamics and external shocks may bias estimates. In this work, we propose a Bayesian DiD framework to allow us to estimate the effect of policies when parallel trends is violated. To address potential deviations from the parallel trends assumption, we introduce a formal sensitivity parameter representing the extent of the violation, specify an autoregressive AR(1) prior on this term to robustly model temporal correlation, and explore a range of prior specifications - including fixed, fully Bayesian, and empirical Bayes (EB) approaches calibrated from pre-treatment data. By systematically comparing posterior treatment effect estimates across prior configurations when evaluating Philadelphia's sweetened beverage tax using Baltimore as a control, we show how Bayesian sensitivity analyses support robust and interpretable policy conclusions under violations of parallel trends.

stat.ME

Computer simulation of surgical interventions for the treatment of refractory pulmonary hypertension

This paper describes computer models of three interventions used for treating refractory pulmonary hypertension (RPH). These procedures create either an atrial septal defect, a ventricular septal defect, or, in the case of a Potts shunt, a patent ductus arteriosus. The aim in all three cases is to generate a right-to-left shunt, allowing for either pressure or volume unloading of the right side of the heart in the setting of right ventricular failure, while maintaining cardiac output. These shunts are created, however, at the expense of introducing de-oxygenated blood into the systemic circulation, thereby lowering the systemic arterial oxygen saturation. The models developed in this paper are based on compartmental descriptions of human hemodynamics and oxygen transport. An important parameter included in our models is the cross-sectional area of the surgically created defect. Numerical simulations are performed to compare different interventions and various shunt sizes and to assess their impact on hemodynamic variables and oxygen saturations. We also create a model for exercise and use it to study exercise tolerance in simulated pre-intervention and post-intervention RPH patients.

q-bio.TO